Microbiology and antimicrobial therapy for diabetic foot infections

Ki Tae Kwon, David G Armstrong

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

In addition to being the prime factor associated with amputation, diabetic foot infections (DFIs) are associated with major morbidity, increasing mortality, and reduced quality of life. The choice of appropriate antibiotics is very important in order to reduce treatment failure, antimicrobial resistance, adverse events, and costs. We reviewed articles on microbiology and antimicrobial therapy and discuss antibiotic selection in Korean patients with DFIs. Similar to Western countries, Staphylococcus aureus is the most common pathogen, with Streptococcus, Enterococcus, Enterobacteriaceae and Pseudomonas also prevalent in Korea. It is recommended that antibiotics are not prescribed for clinically uninfected wounds and that empirical antibiotics be selected based on the clinical features, disease severity, and local antimicrobial resistance patterns. Narrow-spectrum oral antibiotics can be administered for mild infections and broad-spectrum parenteral antibiotics should be administered for some moderate and severe infections. In cases with risk factors for methicillin-resistant S. aureus or Pseudomonas, empirical antibiotics to cover each pathogen should be considered. The Health Insurance Review and Assessment Service standards should also be considered when choosing empirical antibiotics. In Korea, nationwide studies need to be conducted and DFI guidelines should be developed.

Original languageEnglish (US)
Pages (from-to)11-20
Number of pages10
JournalInfection and Chemotherapy
Volume50
Issue number1
DOIs
StatePublished - Mar 1 2018
Externally publishedYes

Fingerprint

Diabetic Foot
Microbiology
Anti-Bacterial Agents
Infection
Therapeutics
Korea
Pseudomonas
Enterococcus
Enterobacteriaceae
Health Insurance
Methicillin-Resistant Staphylococcus aureus
Streptococcus
Treatment Failure
Amputation
Staphylococcus aureus
Quality of Life
Guidelines
Morbidity
Costs and Cost Analysis
Mortality

Keywords

  • Antibiotics
  • Diabetic foot
  • Infections
  • Microbiology

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Microbiology and antimicrobial therapy for diabetic foot infections. / Kwon, Ki Tae; Armstrong, David G.

In: Infection and Chemotherapy, Vol. 50, No. 1, 01.03.2018, p. 11-20.

Research output: Contribution to journalReview article

@article{7df37418d2de43e097989aebc68f9bbe,
title = "Microbiology and antimicrobial therapy for diabetic foot infections",
abstract = "In addition to being the prime factor associated with amputation, diabetic foot infections (DFIs) are associated with major morbidity, increasing mortality, and reduced quality of life. The choice of appropriate antibiotics is very important in order to reduce treatment failure, antimicrobial resistance, adverse events, and costs. We reviewed articles on microbiology and antimicrobial therapy and discuss antibiotic selection in Korean patients with DFIs. Similar to Western countries, Staphylococcus aureus is the most common pathogen, with Streptococcus, Enterococcus, Enterobacteriaceae and Pseudomonas also prevalent in Korea. It is recommended that antibiotics are not prescribed for clinically uninfected wounds and that empirical antibiotics be selected based on the clinical features, disease severity, and local antimicrobial resistance patterns. Narrow-spectrum oral antibiotics can be administered for mild infections and broad-spectrum parenteral antibiotics should be administered for some moderate and severe infections. In cases with risk factors for methicillin-resistant S. aureus or Pseudomonas, empirical antibiotics to cover each pathogen should be considered. The Health Insurance Review and Assessment Service standards should also be considered when choosing empirical antibiotics. In Korea, nationwide studies need to be conducted and DFI guidelines should be developed.",
keywords = "Antibiotics, Diabetic foot, Infections, Microbiology",
author = "Kwon, {Ki Tae} and Armstrong, {David G}",
year = "2018",
month = "3",
day = "1",
doi = "10.3947/ic.2018.50.1.11",
language = "English (US)",
volume = "50",
pages = "11--20",
journal = "Infection and Chemotherapy",
issn = "2093-2340",
publisher = "Taehan Kamyom Hakhoe, Taehan Hwahak Yopop Hakhoe",
number = "1",

}

TY - JOUR

T1 - Microbiology and antimicrobial therapy for diabetic foot infections

AU - Kwon, Ki Tae

AU - Armstrong, David G

PY - 2018/3/1

Y1 - 2018/3/1

N2 - In addition to being the prime factor associated with amputation, diabetic foot infections (DFIs) are associated with major morbidity, increasing mortality, and reduced quality of life. The choice of appropriate antibiotics is very important in order to reduce treatment failure, antimicrobial resistance, adverse events, and costs. We reviewed articles on microbiology and antimicrobial therapy and discuss antibiotic selection in Korean patients with DFIs. Similar to Western countries, Staphylococcus aureus is the most common pathogen, with Streptococcus, Enterococcus, Enterobacteriaceae and Pseudomonas also prevalent in Korea. It is recommended that antibiotics are not prescribed for clinically uninfected wounds and that empirical antibiotics be selected based on the clinical features, disease severity, and local antimicrobial resistance patterns. Narrow-spectrum oral antibiotics can be administered for mild infections and broad-spectrum parenteral antibiotics should be administered for some moderate and severe infections. In cases with risk factors for methicillin-resistant S. aureus or Pseudomonas, empirical antibiotics to cover each pathogen should be considered. The Health Insurance Review and Assessment Service standards should also be considered when choosing empirical antibiotics. In Korea, nationwide studies need to be conducted and DFI guidelines should be developed.

AB - In addition to being the prime factor associated with amputation, diabetic foot infections (DFIs) are associated with major morbidity, increasing mortality, and reduced quality of life. The choice of appropriate antibiotics is very important in order to reduce treatment failure, antimicrobial resistance, adverse events, and costs. We reviewed articles on microbiology and antimicrobial therapy and discuss antibiotic selection in Korean patients with DFIs. Similar to Western countries, Staphylococcus aureus is the most common pathogen, with Streptococcus, Enterococcus, Enterobacteriaceae and Pseudomonas also prevalent in Korea. It is recommended that antibiotics are not prescribed for clinically uninfected wounds and that empirical antibiotics be selected based on the clinical features, disease severity, and local antimicrobial resistance patterns. Narrow-spectrum oral antibiotics can be administered for mild infections and broad-spectrum parenteral antibiotics should be administered for some moderate and severe infections. In cases with risk factors for methicillin-resistant S. aureus or Pseudomonas, empirical antibiotics to cover each pathogen should be considered. The Health Insurance Review and Assessment Service standards should also be considered when choosing empirical antibiotics. In Korea, nationwide studies need to be conducted and DFI guidelines should be developed.

KW - Antibiotics

KW - Diabetic foot

KW - Infections

KW - Microbiology

UR - http://www.scopus.com/inward/record.url?scp=85045192144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045192144&partnerID=8YFLogxK

U2 - 10.3947/ic.2018.50.1.11

DO - 10.3947/ic.2018.50.1.11

M3 - Review article

AN - SCOPUS:85045192144

VL - 50

SP - 11

EP - 20

JO - Infection and Chemotherapy

JF - Infection and Chemotherapy

SN - 2093-2340

IS - 1

ER -